![Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice | bioRxiv Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/04/13/2021.04.13.439482/F5.large.jpg)
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice | bioRxiv
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x675.jpg)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people - ScienceDirect SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124722000523-fx1.jpg)
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people - ScienceDirect
![Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1087/F1.medium.jpg)
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
![Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1087/F3.large.jpg)
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
![mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01446-y/MediaObjects/41591_2021_1446_Fig1_HTML.png)
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Year
![I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate](https://healthydebate.ca/wp-content/uploads/2021/06/E3dkutkX0AweYWR.jpeg)
I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate
![I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate](https://healthydebate.ca/wp-content/uploads/2021/06/are_you_fully_vaccinated-scaled-e1624310241681.jpg)
I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate
![This gives hope': A third COVID-19 vaccine dose can boost protection for organ transplant recipients | Science | AAAS This gives hope': A third COVID-19 vaccine dose can boost protection for organ transplant recipients | Science | AAAS](https://www.science.org/do/10.1126/science.abj9828/abs/Third_vax_1280x720.jpg)